In ZINC since | Heavy atoms | Benign functionality |
---|---|---|
November 10th, 2010 | 26 | Yes |
Popular Name: PHA-793887 PHA-793887
Find On: PubMed — Wikipedia — Google
CAS Numbers: 718630-59-2 , [718630-59-2]
Type pH range | xlogP | Des A‑Pol Apolar desolvation (kcal/mol) | Des Pol Polar desolvation (kcal/mol) | H Don H-bond donors | H Acc H-bond acceptors | Chg Net charge | tPSA (Ų) | MWT Molecular weight (g/mol) | RB Rotatable bonds | DL |
---|---|---|---|---|---|---|---|---|---|---|
Ref Reference (pH 7) | 2.01 | 7.99 | -52.68 | 3 | 7 | 1 | 83 | 362.498 | 4 | ↓ |
Ref Reference (pH 7) | 2.19 | 6.32 | -43.89 | 3 | 7 | 1 | 86 | 362.498 | 4 | ↓ |
Hi High (pH 8-9.5) | 1.64 | 5.69 | -104.44 | 8 | 9 | 2 | 142 | 511.577 | 6 | ↓ |
Mid Mid (pH 6-8) | 2.19 | 5.57 | -44.14 | 3 | 7 | 1 | 86 | 362.498 | 4 | ↓ |
Note Type | Comments | Provided By |
---|---|---|
Target | CDK | Selleck Chemicals |
Code | Description | Organism Class | Affinity (nM) | LE (kcal/mol/atom) | Type |
---|---|---|---|---|---|
GSK3B-1-E | Glycogen Synthase Kinase-3 Beta (cluster #1 Of 7), Eukaryotic | Eukaryotes | 79 | 0.38 | Binding ≤ 10μM |
Z103203-1-O | A375 (cluster #1 Of 3), Other | Other | 396 | 0.34 | Functional ≤ 10μM |
Z80125-1-O | DU-145 (Prostate Carcinoma) (cluster #1 Of 9), Other | Other | 303 | 0.35 | Functional ≤ 10μM |
Z80224-1-O | MCF7 (Breast Carcinoma Cells) (cluster #1 Of 14), Other | Other | 1284 | 0.32 | Functional ≤ 10μM |
Z80390-3-O | PC-3 (Prostate Carcinoma Cells) (cluster #3 Of 10), Other | Other | 601 | 0.33 | Functional ≤ 10μM |
Z80928-3-O | HCT-116 (Colon Carcinoma Cells) (cluster #3 Of 9), Other | Other | 163 | 0.37 | Functional ≤ 10μM |
Z81034-1-O | A2780 (Ovarian Carcinoma Cells) (cluster #1 Of 10), Other | Other | 90 | 0.38 | Functional ≤ 10μM |
Uniprot | Swissprot | Description | Affinity (nM) | LE (kcal/mol/atom) | Type |
---|---|---|---|---|---|
GSK3B_HUMAN | P49841 | Glycogen Synthase Kinase-3 Beta, Human | 79 | 0.38 | Binding ≤ 1μM |
GSK3B_HUMAN | P49841 | Glycogen Synthase Kinase-3 Beta, Human | 79 | 0.38 | Binding ≤ 10μM |
Z81034 | Z81034 | A2780 (Ovarian Carcinoma Cells) | 90 | 0.38 | Functional ≤ 10μM |
Z103203 | Z103203 | A375 | 396 | 0.34 | Functional ≤ 10μM |
Z80125 | Z80125 | DU-145 (Prostate Carcinoma) | 303 | 0.35 | Functional ≤ 10μM |
Z80928 | Z80928 | HCT-116 (Colon Carcinoma Cells) | 163 | 0.37 | Functional ≤ 10μM |
Z80224 | Z80224 | MCF7 (Breast Carcinoma Cells) | 1284 | 0.32 | Functional ≤ 10μM |
Z80390 | Z80390 | PC-3 (Prostate Carcinoma Cells) | 601 | 0.33 | Functional ≤ 10μM |
Description | Species |
---|---|
AKT phosphorylates targets in the cytosol | |
APC truncation mutants have impaired AXIN binding | |
AXIN missense mutants destabilize the destruction complex | |
Beta-catenin phosphorylation cascade | |
Constitutive PI3K/AKT Signaling in Cancer | |
CRMPs in Sema3A signaling | |
Degradation of beta-catenin by the destruction complex | |
disassembly of the destruction complex and recruitment of AXIN to the membrane | |
misspliced GSK3beta mutants stabilize beta-catenin | |
Regulation of HSF1-mediated heat shock response | |
S33 mutants of beta-catenin aren't phosphorylated | |
S37 mutants of beta-catenin aren't phosphorylated | |
S45 mutants of beta-catenin aren't phosphorylated | |
T41 mutants of beta-catenin aren't phosphorylated | |
truncations of AMER1 destabilize the destruction complex |
No pre-computed analogs available. Try a structural similarity search.